\-\ Texto\\:\\ \ \(0\)\
\-\ altered\\ mental\\ status\\.\ \(8\)\
\-\ ascites\ \(66\)\
\-\ splenomegaly\ \(46\)\
\-\ elevated\\ bilirubin\ \(3\)\
\-\ awaiting\\ liver\\ transplant\ \(2\)\
\-\ \\â\\€\\¢\\ high\\ signal\\ intensity\\ changes\\ in\\ the\\ globus\\ pallidus\\ \\-\\ bilateral\\,\\ cerebral\\ peduncles\\,\\ and\\ centrum\\ semiovale\\ ont1\\,\\ t2\\ and\\ flair\ \(0\)\
\-\ \\â\\€\\¢\\ splenomegaly\ \(0\)\
\-\ \\â\\€\\¢\\ cirrhosis\\ of\\ liver\\ and\\ vascular\\ changes\\ of\\ portal\\ hypertension\ \(0\)\
\-\ hepatic\\ encephalopathy\\ w\\/globus\\ pallidus\\ hyperintensity\ \(0\)\
\-\ carbon\\ monoxide\\ exposure\ \(2\)\
\-\ prior\\ manganese\\ exposure\ \(0\)\
\-\ liver\\ failure\ \(5\)\
\-\ tpn\\ \\(total\\ parenteral\\ nutrition\\)\ \(0\)\
\-\ 56\\ year\\ old\\ woman\\ with\\ a\\ 6\\ year\\ history\\ of\\ chronic\\ hepatitis\\.\\ \\ recent\\ decompensation\\ and\\ now\\ on\\ transplant\\ list\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pallidus\\:\\ 0\\.15146356583656867\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.13534386396308157\ \(0\)\
\-\ transplant\\:\\ 0\\.10979474097079996\ \(0\)\
\-\ exposure\\:\\ 0\\.10339699003487156\ \(0\)\
\-\ liver\\:\\ 0\\.10277516898253687\ \(0\)\
\-\ ont1\\:\\ 0\\.10250602818565696\ \(0\)\
\-\ w\\/globus\\:\\ 0\\.10250602818565696\ \(0\)\
\-\ manganese\\:\\ 0\\.09444617724891341\ \(0\)\
\-\ decompensation\\:\\ 0\\.08379163385502789\ \(0\)\
\-\ semiovale\\:\\ 0\\.0816716157527726\ \(0\)\
\-\ centrum\\:\\ 0\\.07832647537542631\ \(0\)\
\-\ parenteral\\:\\ 0\\.07695690519337532\ \(0\)\
\-\ tpn\\:\\ 0\\.07573178291828433\ \(0\)\
\-\ peduncles\\:\\ 0\\.07268103565703443\ \(0\)\
\-\ monoxide\\:\\ 0\\.0718193150505958\ \(0\)\
\-\ globus\\:\\ 0\\.07026662443868276\ \(0\)\
\-\ carbon\\:\\ 0\\.06889705425663178\ \(0\)\
\-\ nutrition\\:\\ 0\\.06889705425663178\ \(0\)\
\-\ awaiting\\:\\ 0\\.06710460449119854\ \(0\)\
\-\ list\\:\\ 0\\.0622067735019392\ \(0\)\
\-\ bilirubin\\:\\ 0\\.059906474160893626\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.05850382314009578\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.05850382314009578\ \(0\)\
\-\ ascites\\:\\ 0\\.05701738858765525\ \(0\)\
\-\ hepatitis\\:\\ 0\\.05701738858765525\ \(0\)\
\-\ changes\\:\\ 0\\.05695460409848978\ \(0\)\
\-\ altered\\:\\ 0\\.05633984314435322\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.05470516929992078\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.05466329133474027\ \(0\)\
\-\ portal\\:\\ 0\\.052302678028258\ \(0\)\
\-\ 56\\:\\ 0\\.052302678028258\ \(0\)\
\-\ mental\\:\\ 0\\.046362845193769736\ \(0\)\
\-\ flair\\:\\ 0\\.0455544026048324\ \(0\)\
\-\ total\\:\\ 0\\.04278744170832833\ \(0\)\
\-\ hepatic\\:\\ 0\\.04149412036983735\ \(0\)\
\-\ hypertension\\:\\ 0\\.03917187270116498\ \(0\)\
\-\ failure\\:\\ 0\\.03892393352129496\ \(0\)\
\-\ intensity\\:\\ 0\\.035914775306736056\ \(0\)\
\-\ status\\:\\ 0\\.03546892233932155\ \(0\)\
\-\ cerebral\\:\\ 0\\.03442379653214036\ \(0\)\
\-\ now\\:\\ 0\\.033966460345367995\ \(0\)\
\-\ elevated\\:\\ 0\\.033712980946035614\ \(0\)\
\-\ recent\\:\\ 0\\.0334037098702302\ \(0\)\
\-\ vascular\\:\\ 0\\.032579107766554614\ \(0\)\
\-\ 6\\:\\ 0\\.0296758158299404\ \(0\)\
\-\ t2\\:\\ 0\\.02812312521802735\ \(0\)\
\-\ chronic\\:\\ 0\\.02798825154543023\ \(0\)\
\-\ high\\:\\ 0\\.027192396059032738\ \(0\)\
\-\ signal\\:\\ 0\\.026198538724102077\ \(0\)\
\-\ prior\\:\\ 0\\.02551293921165539\ \(0\)\
\-\ bilateral\\:\\ 0\\.024114159643191208\ \(0\)\
\-\ woman\\:\\ 0\\.022952359854522167\ \(0\)\
\-\ year\\:\\ 0\\.02223500626216081\ \(0\)\
\-\ \\-\\:\\ 0\\.021299168124515856\ \(0\)\
\-\ history\\:\\ 0\\.01372342485705911\ \(0\)\
\-\ old\\:\\ 0\\.010173658103049472\ \(0\)\
\-\ \\,\\:\\ 0\\.009443374378510025\ \(0\)\
\-\ on\\:\\ 0\\.008417337353086373\ \(0\)\
\-\ \\(\\:\\ 0\\.00839955495632396\ \(0\)\
\-\ and\\:\\ 0\\.008372511894521789\ \(0\)\
\-\ \\)\\:\\ 0\\.008296949908294245\ \(0\)\
\-\ in\\:\\ 0\\.0048999677923285455\ \(0\)\
\-\ a\\:\\ 0\\.004611625602541875\ \(0\)\
\-\ of\\:\\ 0\\.004064086074348433\ \(0\)\
\-\ the\\:\\ 0\\.0016075498221351837\ \(0\)\
\-\ with\\:\\ 0\\.0013605136754638342\ \(0\)\
\-\ \\.\\:\\ 0\\.0012383559103725445\ \(0\)\
